Renovorx to present at the canaccord genuity horizons in oncology virtual conference on april 15, 2024

Los altos, calif.--(business wire)--renovorx, inc. (“renovorx” or the “company”) (nasdaq: rnxt), a clinical-stage biopharmaceutical company developing novel precision oncology therapies based on a local drug-delivery platform, today announced that shaun bagai, renovorx's chief executive officer, will present at the canaccord genuity 2024 horizons in oncology virtual conference to be held on april 15, 2024. mr. bagai will meet with investors and participate in a panel discussion hosted by bill m.
RNXT Ratings Summary
RNXT Quant Ranking